Hormone Therapy in Alpharetta

Why lab work comes before anything else

Hormone therapy is one of the more consequential clinical decisions a wellness program can be involved in, and Aeon treats it that way. No therapy is discussed, let alone started, before a licensed provider reviews relevant lab work and a consistent clinical picture. This is not caution for its own sake: recognized clinical guidance for testosterone therapy in men, for example, requires both a pattern of relevant symptoms and unequivocally low testosterone confirmed on two separate morning, fasting blood draws using a standardized assay, before therapy is considered appropriate (Testosterone Therapy in Men With Hypogonadism, Endocrine Society Clinical Practice Guideline). Symptoms alone, without confirmed lab values, are not sufficient grounds for therapy under that guideline, and they are not sufficient grounds at Aeon either.

Symptoms that justify an evaluation

Many of the symptoms people associate with low hormone levels, low energy, reduced motivation, sleep disturbance, changes in body composition, are genuinely nonspecific: they have several possible causes, hormonal imbalance being only one. The Endocrine Society's guideline for men separates specific findings (very small testes, loss of body hair, incomplete sexual development) from suggestive findings (reduced sexual desire, erectile changes, low bone density) and nonspecific findings (low energy, low mood, poor concentration, reduced muscle bulk), and requires the specific or suggestive category alongside confirmed lab values before therapy is on the table (Endocrine Society guideline). That distinction matters because a member whose real issue is inadequate sleep or an unsustainable training load can present with symptoms that look hormonal but are not, and no amount of hormone therapy addresses a root cause of that kind.

Which markers a clinician evaluates

For men, an evaluation typically centers on total testosterone, measured in the morning after fasting on two separate occasions using a standardized assay, since single or non-standardized measurements are considered unreliable for this purpose (Endocrine Society guideline). For women, evaluation is guided by symptom pattern and life stage, most often perimenopause and menopause, where a professional society position statement notes that hormone therapy remains among the most effective treatments for vasomotor symptoms and genitourinary syndrome of menopause in appropriately selected, healthy, symptomatic women, generally younger than 60 or within 10 years of menopause onset (2022 Hormone Therapy Position Statement, The Menopause Society). Both evaluations sit with a licensed provider, and both require lab and clinical review beyond what a symptom questionnaire alone can establish. This work is coordinated through our clinic and lab services.

Men's and women's hormone health, considered separately

Men and women present with different symptom patterns, different reference ranges, and different risk-benefit calculations, and treating hormone therapy as a single, generic protocol ignores that. For men, the conversation typically centers on testosterone and its role in energy, body composition and sexual function, evaluated against harmonized reference ranges. For women, the conversation more often centers on the menopausal transition, and the therapy discussion weighs symptom severity, age, and time since menopause onset, since the risk-benefit balance for hormone therapy shifts with those factors. Aeon does not run a single protocol for both; a licensed provider evaluates each case on its own clinical picture.

Foundations first, therapy where appropriate

Sleep debt, chronic under-recovery from training, and unmanaged body composition change can all move the same lab markers a hormone evaluation looks at, which is why those foundations are reviewed alongside labs rather than skipped in favor of a faster path to a prescription. Poor sleep, in particular, is a well-documented factor that a clinician will want ruled out or addressed before attributing fatigue or low libido to a hormonal cause, since a member who is sleeping five hours a night and training at a punishing volume can present with a symptom picture that overlaps heavily with a genuine hormonal deficiency without one being present. Addressing training load and sleep first, or in parallel with a clinical evaluation, is part of a careful workup, not a delay tactic.

Where a licensed provider determines, after lab work and consultation, that hormone therapy is clinically appropriate, it proceeds under that provider's ongoing monitoring, including periodic lab rechecks, not as a one-time prescription with no follow-up. Monitoring exists because hormone levels, and the appropriateness of any therapy, are not static; a plan that made sense at the outset can need adjustment as labs and symptoms are reassessed over months. Hormone therapy at Aeon connects into broader programs where relevant, including medical weight loss, and members interested in additional research-stage compounds should review our peptide therapy page, which carries its own separate and more extensive regulatory disclosure.

It is not right for everyone

A clinical evaluation exists to identify who this is appropriate for, and, just as importantly, who it is not. Members whose labs do not confirm a hormonal deficiency, or whose symptoms trace back to sleep, training load or another medical cause, are not offered hormone therapy on request. No outcome or specific result is promised to anyone considering this evaluation; the goal is an accurate clinical picture first, and a decision made by a licensed provider from there.

We would rather a member leave a consultation with an accurate answer, including an answer of "not appropriate right now" or "address sleep and training load first and re-evaluate in three months", than leave with a prescription that a proper workup would not have supported. That is a slower path for some members than they may expect walking in, and it is the only path we consider responsible for a service this consequential.